Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Labrecque

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Anesthesiology|June 1, 1990
Measurement of cerebral blood flow and volume with positron emission tomography during isoflurane administration in the hypocapnic baboonD P Archer, P Labrecque, J L Tyler, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|October 30, 1998
The unanticipated difficult airway with recommendations for managementE T Crosby, R M Cooper, M J Douglas, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Genetic mechanisms of resistance to targeted KRAS inhibitionBianca J Diaz, Max Kops, Sara Bernardo, et al.
Oncotarget|March 26, 2016
The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cellsMark P Labrecque, Mandeep K Takhar, Rebecca Nason, et al.
European Urology|June 23, 2019
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived XenograftsHung-Ming Lam, Holly M Nguyen, Mark P Labrecque, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate CancerDiana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research Communications|October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate CancersAilin Zhang, Nathan A Lau, Alicia Wong, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Anesthesiology|June 1, 1990
Measurement of cerebral blood flow and volume with positron emission tomography during isoflurane administration in the hypocapnic baboonD P Archer, P Labrecque, J L Tyler, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|October 30, 1998
The unanticipated difficult airway with recommendations for managementE T Crosby, R M Cooper, M J Douglas, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Genetic mechanisms of resistance to targeted KRAS inhibitionBianca J Diaz, Max Kops, Sara Bernardo, et al.
Oncotarget|March 26, 2016
The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cellsMark P Labrecque, Mandeep K Takhar, Rebecca Nason, et al.
European Urology|June 23, 2019
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived XenograftsHung-Ming Lam, Holly M Nguyen, Mark P Labrecque, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate CancerDiana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research Communications|October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate CancersAilin Zhang, Nathan A Lau, Alicia Wong, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Pageof 4